glp-1 and nerve pain Therapeutic Effects of Receptor Agonists DPP-4 Inhibitors in Neuropathic Pain: Mechanisms and Clinical Implications Everyone's freaking out about GLP-1s

GLP1 receptor agonists (GLP1RAs) are established treatments for type 2 diabetes mellitus (T2DM) and obesity, with data that support positive effects on hard clinical end points such as cardiovascular events and renal outcomes

(Source 7, 8) The disease can be mild, moderate, or severe, and symptoms include: Hemolytic anemia (a rare anemia caused by the breakdown of red blood cells) Metabolic acidosis (acid buildup) Recurrent bacterial infections Seizures Intellectual disability Ataxia (loss of coordination) (Source 6) Supplementation to Raise Glutathione Concentrations Dietary strategies support the prevention of glutathione depletion

These include: Psoriasis Many psoriasis patients taking weight loss drugs have found they had less itch and scaling

Less common but serious side effects include severe allergic reactions, hypokalemia (low potassium), fluid retention, and heart failure in patients with pre-existing cardiac conditions

it is also being studied for its potential effects on improving skin health, boosting energy levels, and as a supportive treatment in managing various health conditions

These stories, though not scientifically proven, offer valuable perspectives